國立虎尾科技大學 |

Clinical Pharmacokinetic and Pharmacodynamic Drug Interactions Associated with Antimalarials

Record Type:	Language materials, printed : Monograph/item
Title/Author:	Clinical Pharmacokinetic and Pharmacodynamic Drug Interactions Associated with Antimalarials/ by Tony K.L. Kiang, Kyle John Wilby, Mary H.H. Ensom.
Author:	Kiang, Tony K.L.
other author:	Wilby, Kyle John.
Description:	VII, 146 p. 1 illus. in color.online resource. :
Contained By:	Springer Nature eBook
Subject:	Tropical medicine. -
Online resource:	https://doi.org/10.1007/978-3-319-10527-7
ISBN:	9783319105277

Clinical Pharmacokinetic and Pharmacodynamic Drug Interactions Associated with Antimalarials
Kiang, Tony K.L.

Clinical Pharmacokinetic and Pharmacodynamic Drug Interactions Associated with Antimalarials[electronic resource] /by Tony K.L. Kiang, Kyle John Wilby, Mary H.H. Ensom. - 1st ed. 2015. - VII, 146 p. 1 illus. in color.online resource.

Introduction -- Pharmacology of Recommended Antimalarial Agents -- Drug Interaction Potential of Antimalarial Drugs Based on Known Metabolic Properties of Antimalarials -- Pharmacokinetic Drug Interactions Affecting Antimalarials -- Effects of Antimalarials on the Pharmacokinetics of Co-Administered Drugs -- Effects of Antimalarials on the Pharmacokinetics of Co-Administered Antimalarials -- Pharmacodynamic Interactions: Clinical Evidence for Combination Therapy, In Vitro Interactions, and In Vivo Interactions -- Limitations, Future Directions, and Conclusions.

This comprehensive review provides a systematic, unbiased analysis, critique and summary of the available literature and generates novel clinical decision-making algorithms which can aid clinicians and scientists in practice management and research development. Potential mechanisms for the identified drug interactions are deduced from available preclinical and in vitro data which are interpreted in the context of the in vivo findings. Current limitations and gaps in the literature are summarized, and potential future research directions / experimentations are also suggested. In addition to the main objective to review the available clinical pharmacokinetic and pharmacodynamic drug interactions associated with WHO-recommended antimalarial drugs on the market today (i.e. chloroquine, amodiaquine, sulfadoxine, pyrimethamine, mefloquine, artemisinin, artemether, artesunate, dihydroartemisinin, artemotil, lumefantrine, primaquine, atovaquone, proguanil, piperaquine and quinine), this book also provides succinct chapter summaries on the epidemiology of malaria infection, diagnosis and therapeutics, in vivo pharmacology and chemistry, preclinical pharmacology, in vitro pharmacodynamics, in vitro reaction phenotyping, and in vitro drug-drug interaction data associated with the identified antimalarial drugs. .

ISBN: 9783319105277

Standard No.: 10.1007/978-3-319-10527-7doiSubjects--Topical Terms:

673736
Tropical medicine.

LC Class. No.: RC960-962

Dewey Class. No.: 616.9883

Clinical Pharmacokinetic and Pharmacodynamic Drug Interactions Associated with Antimalarials
LDR:03279nam a22003975i 4500 001 960751
003 DE-He213
005 20200629225648.0
007 cr nn 008mamaa
008 201211s2015 gw | s |||| 0|eng d
020 $a 9783319105277 $9 978-3-319-10527-7
024 7 $a 10.1007/978-3-319-10527-7 $2 doi
035 $a 978-3-319-10527-7
050 4 $a RC960-962
072 7 $a MMRT $2 bicssc
072 7 $a MED097000 $2 bisacsh
072 7 $a MKVT $2 thema
082 0 4 $a 616.9883 $2 23
100 1 $a Kiang, Tony K.L. $4 aut $4 http://id.loc.gov/vocabulary/relators/aut $3 1064646
245 1 0 $a Clinical Pharmacokinetic and Pharmacodynamic Drug Interactions Associated with Antimalarials $h [electronic resource] / $c by Tony K.L. Kiang, Kyle John Wilby, Mary H.H. Ensom.
250 $a 1st ed. 2015.
264 1 $a Cham : $b Springer International Publishing : $b Imprint: Adis, $c 2015.
300 $a VII, 146 p. 1 illus. in color. $b online resource.
336 $a text $b txt $2 rdacontent
337 $a computer $b c $2 rdamedia
338 $a online resource $b cr $2 rdacarrier
347 $a text file $b PDF $2 rda
505 0 $a Introduction -- Pharmacology of Recommended Antimalarial Agents -- Drug Interaction Potential of Antimalarial Drugs Based on Known Metabolic Properties of Antimalarials -- Pharmacokinetic Drug Interactions Affecting Antimalarials -- Effects of Antimalarials on the Pharmacokinetics of Co-Administered Drugs -- Effects of Antimalarials on the Pharmacokinetics of Co-Administered Antimalarials -- Pharmacodynamic Interactions: Clinical Evidence for Combination Therapy, In Vitro Interactions, and In Vivo Interactions -- Limitations, Future Directions, and Conclusions.
520 $a This comprehensive review provides a systematic, unbiased analysis, critique and summary of the available literature and generates novel clinical decision-making algorithms which can aid clinicians and scientists in practice management and research development. Potential mechanisms for the identified drug interactions are deduced from available preclinical and in vitro data which are interpreted in the context of the in vivo findings. Current limitations and gaps in the literature are summarized, and potential future research directions / experimentations are also suggested. In addition to the main objective to review the available clinical pharmacokinetic and pharmacodynamic drug interactions associated with WHO-recommended antimalarial drugs on the market today (i.e. chloroquine, amodiaquine, sulfadoxine, pyrimethamine, mefloquine, artemisinin, artemether, artesunate, dihydroartemisinin, artemotil, lumefantrine, primaquine, atovaquone, proguanil, piperaquine and quinine), this book also provides succinct chapter summaries on the epidemiology of malaria infection, diagnosis and therapeutics, in vivo pharmacology and chemistry, preclinical pharmacology, in vitro pharmacodynamics, in vitro reaction phenotyping, and in vitro drug-drug interaction data associated with the identified antimalarial drugs. .
650 0 $a Tropical medicine. $3 673736
650 0 $a Health promotion. $3 565089
650 0 $a Pharmacy. $3 582411
650 1 4 $a Tropical Medicine. $3 668883
650 2 4 $a Health Promotion and Disease Prevention. $3 593964
650 2 4 $a Drug Safety and Pharmacovigilance. $3 1064651
700 1 $a Wilby, Kyle John. $4 aut $4 http://id.loc.gov/vocabulary/relators/aut $3 1064647
700 1 $a Ensom, Mary H.H. $4 aut $4 http://id.loc.gov/vocabulary/relators/aut $3 1064648
710 2 $a SpringerLink (Online service) $3 593884
773 0 $t Springer Nature eBook
776 0 8 $i Printed edition: $z 9783319105284
776 0 8 $i Printed edition: $z 9783319105260
776 0 8 $i Printed edition: $z 9783319381930
856 4 0 $u https://doi.org/10.1007/978-3-319-10527-7
912 $a ZDB-2-SME
912 $a ZDB-2-SXM
950 $a Medicine (SpringerNature-11650)
950 $a Medicine (R0) (SpringerNature-43714)